Plasma levels of myoglobin and MIP-2
. | . | Time after LPS-containing pump implantation . | . | |
|---|---|---|---|---|
| Parameter and genotype . | 0* . | 6 h . | 24 h . | |
| Myoglobin, ng/mL (no. mice) | ||||
| WT | 20.8 ± 6.4 (7) | 20.3 ± 2.0 (11) | 28.9 ± 4.7 (15) | |
| EPCRδ/δ | 18.2 ± 6.4 (7) | 21.8 ± 6.1 (13) | 56.6 ± 11.6 (12)† | |
| MIP-2, pg/mL (no. mice) | ||||
| WT | 2.7 ± 1.4 (7) | 2740 ± 454 (11) | 185 ± 26 (15) | |
| EPCRδ/δ | 3.4 ± 0.4 (7) | 4285 ± 466 (13)† | 322 ± 107 (12) | |
. | . | Time after LPS-containing pump implantation . | . | |
|---|---|---|---|---|
| Parameter and genotype . | 0* . | 6 h . | 24 h . | |
| Myoglobin, ng/mL (no. mice) | ||||
| WT | 20.8 ± 6.4 (7) | 20.3 ± 2.0 (11) | 28.9 ± 4.7 (15) | |
| EPCRδ/δ | 18.2 ± 6.4 (7) | 21.8 ± 6.1 (13) | 56.6 ± 11.6 (12)† | |
| MIP-2, pg/mL (no. mice) | ||||
| WT | 2.7 ± 1.4 (7) | 2740 ± 454 (11) | 185 ± 26 (15) | |
| EPCRδ/δ | 3.4 ± 0.4 (7) | 4285 ± 466 (13)† | 322 ± 107 (12) | |